Z

Zynerba Pharmaceuticals

29 employees

Zynerba Pharmaceuticals, Inc. develops pharmaceutical products via dermal solutions to treat a various neuroscience disorders

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
drug development
transdermal gel
Developer Tools
Health Care
Product Design
Specialty Pharmaceuticals
Fragile X
cannabinoids
Fragile X Syndrome
Epilepsy

Date founded

2014

Funding rounds raised

Total raised

$13M

from 2 investors over 2 rounds

Z

Zynerba Pharmaceuticals raised $13M on October 14, 2014

Investors: Perceptive Advisors

Z

Zynerba Pharmaceuticals raised undisclosed on June 15, 2007

Investors: Keyhorse Capital

FAQ